The pharmacological properties of
Trenbolone side effects. Has anti-inflammatory, antipruritic and antiekssudativnoe effect.
trenbolone side effects induces release of proteins that inhibit phospholipase A2 and collectively known as lipocortin, which control the biosynthesis of inflammatory mediators like prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid.
Prevents the accumulation of neutrophils boundary, inflammatory exudate that reduces cytokine production and inhibits the migration of macrophages, reduces infiltration and granulation processes. Reduces inflammation by reducing the formation of Substance chemotaxis (impact on “late” reaction allergies), inhibits the development of “immediate” allergic reaction (due to inhibition of the production of arachidonic acid metabolites and decrease the release of mast cell mediators of inflammation).
With the daily application of a cream to children older than 2 years allergic dermatitis, the therapeutic effect is 3 weeks.
Absorption cream Gistan-H low. After 8 hours after application on intact skin (without occlusive dressings) detected in the systemic circulation of about 0.4% of the dose. When inflammation and damage to skin absorption increases.
Indications for use
inflammation and itching with skin dermatoses (including psoriasis, atopic dermatitis, seborrheic dermatitis), which is shown in trenbolone side effects therapy.
– Hypersensitivity to any component of the drug or to other corticosteroids.
– Rosacea, perioral dermatitis.
– Bacterial, viral (Herpes simplex, chicken pox, Herpes zoster), or a fungal infection of the skin.
– Tuberculosis, syphilis.
– Post-vaccination reactions.
– Pregnancy (treatment of large areas of skin, long-term care);
– lactation (used in high doses and / or for a long time).
– Children under 2 years old.
application to the skin of the face and intertriginous skin surface, the use of occlusive dressings, as well as the treatment of large areas of skin and / or long-term treatment (particularly in children).
Use during pregnancy and lactation
The safety of Trenbolone side effects furoate during pregnancy and lactation has not been studied.
trenbolone side effects crosses the placental barrier. Avoid long-term treatment and the use of large doses during pregnancy due to the risk of negative effects on fetal development.
Corticosteroids are excreted in breast milk. In the case where the use of corticosteroids expected at high doses and / or for a long time, discontinue breastfeeding.
Dosage and administration
thin layer of product applied to the affected skin once daily.
Duration of treatment: 7-28 days, determined by the effectiveness of therapy, and tolerability by the patient, presence and severity of side effects.
Side effects Local reactions: . Burning, itching, paresthesia, folliculitis, acne, skin atrophy, hypertrichosis, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, the accession of secondary infection, striae, miliaria probability of occurrence of these adverse events is increased by the use of occlusive . dressings Systemic action: the application of external forms SSC for a long time and / or for the treatment of large areas of skin (the total area of the coating over the area of the patient’s hand), or by using occlusive dressings, especially in children and teenagers, can have side effects characteristic trenbolone side effects for systemic effects, including adrenal insufficiency and Cushing’s syndrome.
Overdose Symptoms: inhibition of the function of the hypothalamic-pituitary-adrenal system (including secondary adrenal insufficiency). Treatment: symptomatic. If necessary – correction of electrolyte imbalance, removal of the drug (for long-term treatment – phasing out).
Interaction with other medicinal products
is not revealed.
If no effect within 2 weeks of therapy, the drug should clarify the diagnosis.
When applied to large areas of the skin for a long time, especially in the application of occlusive dressings may develop corticosteroids systemic effects.
Given this, it is necessary to control the function of the hypothalamic-pituitary-adrenal axis .
avoid getting product in eyes.
propylene glycol, which is a part, can cause irritation at the site of application. In such cases, use of the drug should be discontinued and appropriate treatment.
It should be borne in mind that corticosteroids can change the display of certain skin diseases, which may hinder the diagnosis. In addition, the use of corticosteroids may be the cause of the delay wound healing.
In long-term treatment of trenbolone side effects sudden cessation of therapy can lead to rebound syndrome, which manifests itself in the form of dermatitis with intense redness and burning sensation. So after prolonged treatment abolition of the drug should be made gradually, for example, going to the intermittent regimen before its full stop.
in connection with the fact that in children the value of the ratio of surface area and body weight greater than that of adults, children are at greater risk of suppression of the hypothalamic-pituitary-adrenal system and the development of the syndrome Cushing when applying any topical corticosteroids. Long-term treatment of children corticosteroids may impair their growth and development. Use of the drug in children for more than 3 weeks has not been studied.
Children should receive the minimum dose sufficient to achieve the effect.